Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blueberry: Dexamethasone in Tonsillectomy
NCT04188431Phase 4Terminated
- Start
- Nov 2020
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms). Primary endpoint: Reoperation for postoperative bleeding at 30 days. Started Nov 2020; status: terminated.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT04188431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04188431.